Related Experiment Videos

Opportunistic infections after renal transplantation

Matthias P Hörl1, Michael Schmitz, Katrin Ivens

  • 1Department of Nephrology and Rheumatology, University of Düsseldorf, Düsseldorf, Germany.

Current Opinion in Urology
|February 23, 2002
PubMed

Insights

New immunosuppressive drugs increase the risk of rare but severe opportunistic infections in kidney transplant recipients. Early detection and treatment are crucial for managing these complications.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • Kidney transplant recipients on immunosuppressive therapy are at high risk for opportunistic infections.
  • The use of newer immunosuppressants like tacrolimus and mycophenolate mofetil has altered the landscape of these infections.
  • Rare pathogens pose significant clinical challenges in this patient population.

Purpose of the Study:

  • To review recently encountered opportunistic infections in kidney transplant recipients.
  • To highlight specific infectious agents, including human herpesviruses, polyomavirus, parvovirus B19, varicella zoster virus, Nocardia, and Listeria monocytogenes.
  • To emphasize the importance of considering these infections in differential diagnoses.

Main Methods:

  • Overview of clinical cases and literature review.
  • Identification of opportunistic pathogens encountered at a transplantation center.
  • Discussion of diagnostic and therapeutic advancements.

Main Results:

  • Several rare opportunistic infections were identified, including human herpesviruses 6-8, polyomavirus, parvovirus B19, varicella zoster virus, Nocardia, and Listeria monocytogenes.
  • These infections are increasingly recognized due to modern immunosuppressive regimens.
  • Newer diagnostic and treatment strategies are becoming available.

Conclusions:

  • Opportunistic infections are a critical concern in kidney transplant recipients on immunosuppression.
  • Awareness of rare pathogens and their association with new immunosuppressive drugs is essential.
  • Advancements in diagnostics and therapeutics offer improved management of these severe complications.

Related Concept Videos